Valuation : Abbott Laboratories

Market Cap 197B 169B 159B 145B 273B 18,861B 274B 1,876B 733B 9,505B 741B 725B 31,464B P/E 2026 *
32x
P/E 2027 * 24.7x
Enterprise Value 221B 190B 178B 163B 307B 21,148B 308B 2,104B 822B 10,658B 831B 813B 35,279B EV / Sales 2026 *
4.4x
EV / Sales 2027 * 4x
Free-Float
86.16%
Yield 2026 *
2.3%
Yield 2027 * 2.46%
1 week-2.19%
Current month+4.02%
1 month+3.84%
3 months+29.84%
6 months-2.49%
Current year-9.31%
1 week 95.52
Extreme 95.52
100.3
1 month 90.36
Extreme 90.36
100.3
3 years 69.64
Extreme 69.64
134.1
5 years 69.64
Extreme 69.64
134.1
10 years 34
Extreme 34.003
134.1
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Change 5-day change 1-year change 3-year change Capi.($)
-2.43%+0.18%-15.18%-0.82% 197B
-2.20%-2.48%-15.20%+7.08% 197B
-2.23%-4.42%-2.40%+9.47% 118B
-2.00%+1.30%+10.88%+78.98% 62.55B
-2.00%-3.74%+27.02%+53.48% 52.4B
-1.09%+0.28%-3.06%-32.81% 51.81B
+0.37%-0.66%+17.30%-11.38% 33.57B
+0.20%+2.18% - - 30.34B
-1.09%-1.90%+41.55%-12.10% 24.63B
-0.47%+3.56%-3.25%+19.21% 23.81B
Average -1.17%+0.67%+6.41%+12.34% 66.04B
Weighted average by Cap. -1.69%+0.01%-3.70%+10.73%

Financials

2026 *2027 *
Net sales 50.3B 43.18B 40.39B 37.01B 69.67B 4,805B 69.92B 478B 187B 2,422B 189B 185B 8,016B 54.65B 46.9B 43.88B 40.21B 75.69B 5,220B 75.96B 519B 203B 2,631B 205B 201B 8,708B
Net income 6.23B 5.35B 5B 4.59B 8.63B 595B 8.66B 59.23B 23.15B 300B 23.4B 22.89B 993B 7.92B 6.8B 6.36B 5.83B 10.98B 757B 11.02B 75.32B 29.44B 382B 29.75B 29.11B 1,263B
Net Debt 23.94B 20.55B 19.22B 17.62B 33.16B 2,287B 33.28B 228B 88.93B 1,152B 89.88B 87.93B 3,815B 20.96B 17.99B 16.83B 15.42B 29.03B 2,002B 29.13B 199B 77.85B 1,009B 78.68B 76.97B 3,340B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
-
Date Price Change
26-08-27 €95.64 -2.43%
26-08-26 €98.02 -1.41%
26-08-25 €99.42 -0.42%
26-08-24 €99.84 +0.30%
26-08-21 €99.54 +1.80%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
111.59USD
Average target price
120.20USD
Spread / Average Target
+7.72%

Quarterly revenue - Rate of surprise